Global RNAi for Therapeutic Market Research Report 2016

Publisher Name :
Date: 09-Oct-2016
No. of pages: 115
Inquire Before Buying

Notes:

Production, means the output of RNAi for Therapeutic

Revenue, means the sales value of RNAi for Therapeutic

This report studies RNAi for Therapeutic in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

- Alnylam Pharmaceuticals

- Arbutus Biopharma (Tekmira)

- Arrowhead Research

- Dicerna Pharmaceuticals

- Mirna Therapeutics

- Quark Pharmaceuticals

- RXi Pharmaceuticals

- Silence Therapeutics

- Benitec Biopharma

- Miragen Therapeutics

- Sylentis

- Gradalis

- Sirnaomics

- Silenseed

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of RNAi for Therapeutic in these regions, from 2011 to 2021 (forecast), like

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

- siRNA

- miRNA

- shRNA

Split by application, this report focuses on consumption, market share and growth rate of RNAi for Therapeutic in each application, can be divided into

- Cancer

- Cardiovascular

- HBV

Global RNAi for Therapeutic Market Research Report 2016

Table of Contents
Global RNAi for Therapeutic Market Research Report 2016
1 RNAi for Therapeutic Market Overview
1.1 Product Overview and Scope of RNAi for Therapeutic
1.2 RNAi for Therapeutic Segment by Type
1.2.1 Global Production Market Share of RNAi for Therapeutic by Type in 2015
1.2.2 siRNA
1.2.3 miRNA
1.2.4 shRNA
1.3 RNAi for Therapeutic Segment by Application
1.3.1 RNAi for Therapeutic Consumption Market Share by Application in 2015
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 HBV
1.4 RNAi for Therapeutic Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of RNAi for Therapeutic (2011-2021)
2 Global RNAi for Therapeutic Market Competition by Manufacturers
2.1 Global RNAi for Therapeutic Production and Share by Manufacturers (2015 and 2016)
2.2 Global RNAi for Therapeutic Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global RNAi for Therapeutic Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers RNAi for Therapeutic Manufacturing Base Distribution, Sales Area and Product Type
2.5 RNAi for Therapeutic Market Competitive Situation and Trends
2.5.1 RNAi for Therapeutic Market Concentration Rate
2.5.2 RNAi for Therapeutic Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global RNAi for Therapeutic Production, Revenue (Value) by Region (2011-2016)
3.1 Global RNAi for Therapeutic Production by Region (2011-2016)
3.2 Global RNAi for Therapeutic Production Market Share by Region (2011-2016)
3.3 Global RNAi for Therapeutic Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
4 Global RNAi for Therapeutic Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global RNAi for Therapeutic Consumption by Regions (2011-2016)
4.2 North America RNAi for Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe RNAi for Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China RNAi for Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan RNAi for Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia RNAi for Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India RNAi for Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)
5 Global RNAi for Therapeutic Production, Revenue (Value), Price Trend by Type
5.1 Global RNAi for Therapeutic Production and Market Share by Type (2011-2016)
5.2 Global RNAi for Therapeutic Revenue and Market Share by Type (2011-2016)
5.3 Global RNAi for Therapeutic Price by Type (2011-2016)
5.4 Global RNAi for Therapeutic Production Growth by Type (2011-2016)
6 Global RNAi for Therapeutic Market Analysis by Application
6.1 Global RNAi for Therapeutic Consumption and Market Share by Application (2011-2016)
6.2 Global RNAi for Therapeutic Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global RNAi for Therapeutic Manufacturers Profiles/Analysis
7.1 Alnylam Pharmaceuticals
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 RNAi for Therapeutic Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Arbutus Biopharma (Tekmira)
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 RNAi for Therapeutic Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Arrowhead Research
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 RNAi for Therapeutic Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Arrowhead Research RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Dicerna Pharmaceuticals
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 RNAi for Therapeutic Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Mirna Therapeutics
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 RNAi for Therapeutic Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Mirna Therapeutics RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Quark Pharmaceuticals
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 RNAi for Therapeutic Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Quark Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 RXi Pharmaceuticals
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 RNAi for Therapeutic Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 RXi Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Silence Therapeutics
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 RNAi for Therapeutic Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Silence Therapeutics RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Benitec Biopharma
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 RNAi for Therapeutic Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Benitec Biopharma RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Miragen Therapeutics
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 RNAi for Therapeutic Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Miragen Therapeutics RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Sylentis
7.12 Gradalis
7.13 Sirnaomics
7.14 Silenseed
8 RNAi for Therapeutic Manufacturing Cost Analysis
8.1 RNAi for Therapeutic Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of RNAi for Therapeutic
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 RNAi for Therapeutic Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global RNAi for Therapeutic Market Forecast (2016-2021)
12.1 Global RNAi for Therapeutic Production, Revenue Forecast (2016-2021)
12.2 Global RNAi for Therapeutic Production, Consumption Forecast by Regions (2016-2021)
12.3 Global RNAi for Therapeutic Production Forecast by Type (2016-2021)
12.4 Global RNAi for Therapeutic Consumption Forecast by Application (2016-2021)
12.5 RNAi for Therapeutic Price Forecast (2016-2021)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of RNAi for Therapeutic
Figure Global Production Market Share of RNAi for Therapeutic by Type in 2015
Figure Product Picture of siRNA
Table Major Manufacturers of siRNA
Figure Product Picture of miRNA
Table Major Manufacturers of miRNA
Figure Product Picture of shRNA
Table Major Manufacturers of shRNA
Table RNAi for Therapeutic Consumption Market Share by Application in 2015
Figure Cancer Examples
Figure Cardiovascular Examples
Figure HBV Examples
Figure North America RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure China RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure India RNAi for Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global RNAi for Therapeutic Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global RNAi for Therapeutic Capacity of Key Manufacturers (2015 and 2016)
Table Global RNAi for Therapeutic Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global RNAi for Therapeutic Capacity of Key Manufacturers in 2015
Figure Global RNAi for Therapeutic Capacity of Key Manufacturers in 2016
Table Global RNAi for Therapeutic Production of Key Manufacturers (2015 and 2016)
Table Global RNAi for Therapeutic Production Share by Manufacturers (2015 and 2016)
Figure 2015 RNAi for Therapeutic Production Share by Manufacturers
Figure 2016 RNAi for Therapeutic Production Share by Manufacturers
Table Global RNAi for Therapeutic Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global RNAi for Therapeutic Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global RNAi for Therapeutic Revenue Share by Manufacturers
Table 2016 Global RNAi for Therapeutic Revenue Share by Manufacturers
Table Global Market RNAi for Therapeutic Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market RNAi for Therapeutic Average Price of Key Manufacturers in 2015
Table Manufacturers RNAi for Therapeutic Manufacturing Base Distribution and Sales Area
Table Manufacturers RNAi for Therapeutic Product Type
Figure RNAi for Therapeutic Market Share of Top 3 Manufacturers
Figure RNAi for Therapeutic Market Share of Top 5 Manufacturers
Table Global RNAi for Therapeutic Capacity by Regions (2011-2016)
Figure Global RNAi for Therapeutic Capacity Market Share by Regions (2011-2016)
Figure Global RNAi for Therapeutic Capacity Market Share by Regions (2011-2016)
Figure 2015 Global RNAi for Therapeutic Capacity Market Share by Regions
Table Global RNAi for Therapeutic Production by Regions (2011-2016)
Figure Global RNAi for Therapeutic Production and Market Share by Regions (2011-2016)
Figure Global RNAi for Therapeutic Production Market Share by Regions (2011-2016)
Figure 2015 Global RNAi for Therapeutic Production Market Share by Regions
Table Global RNAi for Therapeutic Revenue by Regions (2011-2016)
Table Global RNAi for Therapeutic Revenue Market Share by Regions (2011-2016)
Table 2015 Global RNAi for Therapeutic Revenue Market Share by Regions
Table Global RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table North America RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table China RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table India RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Table Global RNAi for Therapeutic Consumption Market by Regions (2011-2016)
Table Global RNAi for Therapeutic Consumption Market Share by Regions (2011-2016)
Figure Global RNAi for Therapeutic Consumption Market Share by Regions (2011-2016)
Figure 2015 Global RNAi for Therapeutic Consumption Market Share by Regions
Table North America RNAi for Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Europe RNAi for Therapeutic Production, Consumption, Import & Export (2011-2016)
Table China RNAi for Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Japan RNAi for Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia RNAi for Therapeutic Production, Consumption, Import & Export (2011-2016)
Table India RNAi for Therapeutic Production, Consumption, Import & Export (2011-2016)
Table Global RNAi for Therapeutic Production by Type (2011-2016)
Table Global RNAi for Therapeutic Production Share by Type (2011-2016)
Figure Production Market Share of RNAi for Therapeutic by Type (2011-2016)
Figure 2015 Production Market Share of RNAi for Therapeutic by Type
Table Global RNAi for Therapeutic Revenue by Type (2011-2016)
Table Global RNAi for Therapeutic Revenue Share by Type (2011-2016)
Figure Production Revenue Share of RNAi for Therapeutic by Type (2011-2016)
Figure 2015 Revenue Market Share of RNAi for Therapeutic by Type
Table Global RNAi for Therapeutic Price by Type (2011-2016)
Figure Global RNAi for Therapeutic Production Growth by Type (2011-2016)
Table Global RNAi for Therapeutic Consumption by Application (2011-2016)
Table Global RNAi for Therapeutic Consumption Market Share by Application (2011-2016)
Figure Global RNAi for Therapeutic Consumption Market Share by Application in 2015
Table Global RNAi for Therapeutic Consumption Growth Rate by Application (2011-2016)
Figure Global RNAi for Therapeutic Consumption Growth Rate by Application (2011-2016)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alnylam Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Market Share (2011-2016)
Table Arbutus Biopharma (Tekmira) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Arbutus Biopharma (Tekmira) RNAi for Therapeutic Market Share (2011-2016)
Table Arrowhead Research Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arrowhead Research RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Arrowhead Research RNAi for Therapeutic Market Share (2011-2016)
Table Dicerna Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dicerna Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Dicerna Pharmaceuticals RNAi for Therapeutic Market Share (2011-2016)
Table Mirna Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mirna Therapeutics RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Mirna Therapeutics RNAi for Therapeutic Market Share (2011-2016)
Table Quark Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Quark Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Quark Pharmaceuticals RNAi for Therapeutic Market Share (2011-2016)
Table RXi Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table RXi Pharmaceuticals RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure RXi Pharmaceuticals RNAi for Therapeutic Market Share (2011-2016)
Table Silence Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Silence Therapeutics RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Silence Therapeutics RNAi for Therapeutic Market Share (2011-2016)
Table Benitec Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Benitec Biopharma RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Benitec Biopharma RNAi for Therapeutic Market Share (2011-2016)
Table Miragen Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Miragen Therapeutics RNAi for Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)
Figure Miragen Therapeutics RNAi for Therapeutic Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNAi for Therapeutic
Figure Manufacturing Process Analysis of RNAi for Therapeutic
Figure RNAi for Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of RNAi for Therapeutic Major Manufacturers in 2015
Table Major Buyers of RNAi for Therapeutic
Table Distributors/Traders List
Figure Global RNAi for Therapeutic Production and Growth Rate Forecast (2016-2021)
Figure Global RNAi for Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Table Global RNAi for Therapeutic Production Forecast by Regions (2016-2021)
Table Global RNAi for Therapeutic Consumption Forecast by Regions (2016-2021)
Table Global RNAi for Therapeutic Production Forecast by Type (2016-2021)
Table Global RNAi for Therapeutic Consumption Forecast by Application (2016-2021)
  • Global Coronary Artery Bypass Grafts (CABG) Market 2017-2021
    Published: 15-Nov-2017        Price: US 3500 Onwards        Pages: 93
    About Coronary Artery Bypass Grafts (CABG) CABG is a surgical procedure performed to improve blood flow to the heart. It is used for patients suffering with a severe coronary heart disease (CHD). CHD is a disease that leads to deposition of plaque inside arteries and disrupts the flow of oxygen to the heart. During the CABG procedure, a healthy artery or vein from the body is connected or grafted to the blocked coronary artery to create a new path for oxygen-rich blood to flow to the hear......
  • Global DNA Probe-based Diagnostic Market 2017-2021
    Published: 15-Nov-2017        Price: US 3500 Onwards        Pages: 85
    About DNA Probe-based Diagnostic The DNA probe is a basic component in most molecular diagnostic techniques. The DNA probe is a labeled DNA strand synthesized in the laboratory. Its purpose is to hybridize with the target nucleic acid molecule to be identified from a biological sample. A probe is composed of a strand of 30-40 nucleotides called oligonucleotides. These oligonucleotides are labeled with a detector molecule. When hybridization occurs between the probe and the target organism......
  • Global Internal Urinary Catheters Market 2017-2021
    Published: 15-Nov-2017        Price: US 3500 Onwards        Pages: 120
    About Internal Urinary Catheters Urinary catheters are used for treating incontinence in patients with less or no control over the bladder. Urinary incontinence may occur due to several deformities such as the abnormal function of the lower urinary tract, overactive bladder, bladder disorders, spinal cord injury, multiple sclerosis, and spina bifida. In older people, the incontinence is associated with multiple factors such as chronic disease conditions, age-related changes, and infection......
  • Global Premature Ejaculation Treatment Market 2017-2021
    Published: 15-Nov-2017        Price: US 3500 Onwards        Pages: 84
    About Premature Ejaculation Treatment Premature ejaculation is one of the most common sexual dysfunctions occurring in men. Ejaculation happens sooner than desired, either shortly or before penetration, resulting in distress to either one or both partners involved in sexual intercourse. There is no exact cause that can be associated with the condition though mostly, premature ejaculation can be attributed to personal distress and anxiety. It can affect an individual's relationship with hi......
  • Sexual Wellness Market in the US 2017-2021
    Published: 15-Nov-2017        Price: US 3500 Onwards        Pages: 89
    About Sexual Wellness Sexual wellness widely refers to wellbeing related to sexuality. Products that enhance sexual health and experience include condoms, sensual lingerie, lubricants, sex toys, contraceptives, costumes, and enhancement supplements. These products enhance pleasure during intimacy. They are entering the mainstream media, and the market is getting bigger every year because of their growing acceptance. The analysts forecast sexual wellness market in the US to ......
  • Global Companion Animal Specialty Drugs Market 2017-2021
    Published: 14-Nov-2017        Price: US 3500 Onwards        Pages: 88
    About Companion Animal Specialty Drugs Companion animals are becoming a part of urban population. The factors that have contributed to increased companion animal ownership includes nuclear families and the growing geriatric population living independently. This increasing pet adoption is essentially driving the demand for companion animal specialty drugs, because of the growing prevalence of various diseases and awareness toward pet nutrition. The analysts forecast global c......
  • Global Assisted Reproductive Technology Market in Fertility Clinics 2017-2021
    Published: 13-Nov-2017        Price: US 3500 Onwards        Pages: 99
    About Assisted Reproductive Technology in Fertility Clinics Infertility is a medical condition that affects both men and women. Generally, a couple is considered infertile when they are unable to conceive after a 12-month period of unprotected sexual intercourse. ART consists of a wide range of procedures that are used to treat infertility in men and women. These procedures are rendered to patients primarily in clinics, which treat infertility and are collectively referred to as fertility......
  • Global Antiretroviral Therapy Market 2017-2021
    Published: 13-Nov-2017        Price: US 3500 Onwards        Pages: 81
    About Antiretroviral Therapy The antiretroviral therapy (ART) market is primarily related to the treatment of human immunodeficiency virus (HIV) infection. Antiretroviral drugs are usually taken in combination to prevent the growth of the virus, which slows the growth of HIV infection. The major drivers for the ART market include the rising awareness of retroviral infection, aggressive innovation in diagnostic techniques, the introduction of novel drugs through significant investments mad......
  • Global Ostomy Products Market 2018-2022
    Published: 10-Nov-2017        Price: US 3500 Onwards        Pages: 141
    About Ostomy Products An ostomy is a surgical procedure that is performed to create an opening in the abdomen to excrete the waste products. Such surgical openings in the abdomen are known as artificial stoma. Based on the complications, artificial stomas can be temporary or permanent. People who undergo temporary ostomy procedure also undergo therapeutic procedures, which help to recover the intestine. In such cases, stomas can be reversed. In both temporary and permanent ostomy procedur......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs